Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950116-04-003819
Filing Date
2004-12-17
Accepted
2004-12-17 17:20:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sc13ga.txt SC 13G/A 10443
  Complete submission text file 0000950116-04-003819.txt   12487
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Subject) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48323 | Film No.: 041212152
SIC: 2834 Pharmaceutical Preparations

Mailing Address 365 W END AVE APARTMENT 10A NEW YORK NY 10024
Business Address 1330 AVENUE OF THE AMERICAS NEW YORK NY 10019 212 580 1665
LOBELL J JAY (Filed by) CIK: 0001172659 (see all company filings)